Tumor Necrosis Factor Alpha News and Research

RSS
Animal study suggests ibuprofen can reduce lung inflammation in elderly

Animal study suggests ibuprofen can reduce lung inflammation in elderly

GILZ protein key to preventing bone loss, researchers report

GILZ protein key to preventing bone loss, researchers report

Bacteria that aid in digestion help keep intestinal lining intact

Bacteria that aid in digestion help keep intestinal lining intact

Tumor necrosis factor alpha antagonists not linked with increased risk of cancer

Tumor necrosis factor alpha antagonists not linked with increased risk of cancer

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

Study: Ginsenoside Rb1 attenuates neuronal damage following cerebral ischemia

Study: Ginsenoside Rb1 attenuates neuronal damage following cerebral ischemia

High sodium intake correlates with fatness and inflammation in adolescents

High sodium intake correlates with fatness and inflammation in adolescents

Practicing yoga for atleast 3 months can reduce fatigue and inflammation in breast cancer survivors

Practicing yoga for atleast 3 months can reduce fatigue and inflammation in breast cancer survivors

Elevated BACE1 activity in mild cognitive impairment could be early indicator of AD, says study

Elevated BACE1 activity in mild cognitive impairment could be early indicator of AD, says study

Scientists discover how lymphotoxin controls production of immunoglobulins in gut

Scientists discover how lymphotoxin controls production of immunoglobulins in gut

FDA advisory committee backs Takeda's vedolizumab for treatment of ulcerative colitis, Crohn's disease

FDA advisory committee backs Takeda's vedolizumab for treatment of ulcerative colitis, Crohn's disease

Gene variations in response to injury can impact clinical outcomes in TBI

Gene variations in response to injury can impact clinical outcomes in TBI

Finding highlights new ways of treating inflammation disorders

Finding highlights new ways of treating inflammation disorders

Anti-inflammatory mechanism leads to development of oral medications for atherosclerosis, IBS

Anti-inflammatory mechanism leads to development of oral medications for atherosclerosis, IBS

ACR journals publish guide that provides new treatments for children with systemic JIA

ACR journals publish guide that provides new treatments for children with systemic JIA

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

Reversing inflammation in fluid near brain's cortex may provide solution to Parkinson's disease

Reversing inflammation in fluid near brain's cortex may provide solution to Parkinson's disease

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease